¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chain fiber"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • reverse transcriptase polymerase chain reaction
    ¿ªÀü»çÈ¿¼ÒÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ
  • sympathetic chain
    ±³°¨½Å°æÁÙ±â
  • side chain
    °ç»ç½½
  • side chain isomerism
    ¿·»ç½½À̼º
  • annular reticular fiber
    °í¸®±×¹°¼¶À¯
  • apical fiber
    »Ñ¸®³¡¼¶À¯, ±Ù÷¼¶À¯
  • association fiber
    ¿¬ÇÕ¼¶À¯
  • attractive fiber
    ´ç±è¼¶À¯, °ßÀμ¶À¯
  • autonomic nerve fiber
    ÀÚÀ²½Å°æ¼¶À¯
  • axial fiber
    ̈ȏ
  • A-delta fiber
    Aµ¨Å¸½Å°æ¼¶À¯
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼¶À¯
  • afferent fiber
    µé½Å°æ¼¶À¯, ±¸½É½Å°æ¼¶À¯
  • afferent nerve fiber
    µé½Å°æ¼¶À¯, ±¸½É½Å°æ¼¶À¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • light-chain nephropathy
    °¡º­¿î»ç½½ÄáÆÏº´Áõ
  • straight chain molecule
    °ðÀº»ç½½ºÐÀÚ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • A-delta fiber
    ¿¡À̵¨Å¸½Å°æ¼¶À¯
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼¶À¯
  • afferent fiber
    (¢¡afferent nerve fiber) µé½Å°æ¼¶À¯
  • afferent nerve fiber
    µé½Å°æ¼¶À¯
  • alveolar fiber
    ÀÌÆ²¼¶À¯
  • annular reticular fiber
    µ¹¸²¼¼¸Á¼¶À¯
  • apical fiber
    »Ñ¸®³¡¼¶À¯
  • association fiber
    ¿¬ÇÕ¼¶À¯
  • attractive fiber
    ´ç±è¼¶À¯, °ßÀμ¶À¯
  • autonomic nerve fiber
    ÀÚÀ²½Å°æ¼¶À¯
  • axial fiber
    (¢¡axon) Ãà»è
  • bag fiber
    (¢¡nuclear bag fiber) ÇÙÁָӴϼ¶À¯, ÇÙÁָӴϱÙÀ°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Fiber
    ¼¶À¯(àéë«)
  • H band in skeletal muscle fiber
    H ¶ì
  • Henles fiber layer
    Çî·¹½Å°æ¼¶À¯Ãþ
  • Interadicular fiber
    »Ñ¸®»çÀ̼¶À¯
  • NANC nerve fiber
    ºñÀÚÀ²½Å°æ¼º ½Å°æ¼¶À¯(¾Æµå·¹³¯¸°,Äݸ°
  • Purkinje s fiber
    ǮŲ¿¹¼¶À¯ ÀÚ±ØÀüµµ°è±Ù¼¶À¯ .
  • afferent nerve fiber
    µé½Å°æ¼¶À¯
  • alpha fiber
    ¾ËÆÄ(½Å°æ)¼¶À¯
  • amyelinated nerve fiber
    ¹«¼ö½Å°æ¼¶À¯(ÙíâÐãêÌèàéë«).
  • anular reticular fiber
    µ¹¸²¼¼¸Á¼¶À¯
  • apical fiber
    »Ñ¸®³¡¼¶À¯
  • fusimotor fiber
    ±Ù¹æÃ߿¼¶À¯.
  • fusimotor fiber
    ±Ù¹æÃ߿(ÐÉÛ·õßê¡ÔÑ)¼¶À¯(àéë«).
  • gamma motor fiber
    °¨¸¶¿îµ¿¼¶À¯(¡­ê¡ÔÑàéë«).
  • giant nerve fiber
    °Å´ë½Å°æ¼¶À¯.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain, heavy
    Áß¼â, Á߻罽, H¼â
  • chain, joining
    ¿¬°á»ç½½, ¿¬°á¼â (=J»ç½½)
  • chain, kappa (¥ê)
    Ä«ÆÄ»ç½½, Ä«ÆÄ¼â
  • chain, lambda (¥ë)
    ¶÷´Ù»ç½½, ¶÷´Ù¼â
  • chain, light
    °æ¼â, °æ»ç½½, L¼â
  • chain, mu (¥ì)
    ¹Â»ç½½, ¹Â¼â
  • chromosome chain
    ¿°»öü¼â(¡­áð).
  • delta (¥ä) chain
    ÅÚŸ»ç½½, µ¨Å¸¼â
  • epsilon (¥å) chain
    ¿¦½Ç·Ð»ç½½, ¿¦½Ç·Ð¼â
  • food chain =biological concentration
    ½Äǰ¿¬¼â(¡­ææáð).
  • gamma (¥ã) chain
    °¨¸¶»ç½½, °¨¸¶¼â
  • gamma heavy chain disease
    °¨¸¶Á߼⺴(¡­ñìáðÜ»).
  • gamma heavy chain disease
    °¨¸¶Á߼⺴
  • gamma heavy chain disease
    °¨¸¶Á߼⺴(¡­ñìáðÜ»).
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Chromatin fiber of satellite
    ¿°»öÁú¼¶À¯
    [¿¾ ¿ë¾î] À§¼º»ç
  • Principal fiber
    À¸¶ä¼¶À¯
    [¿¾ ¿ë¾î] ÁÖ¼¶À¯
  • Transitory fiber
    ÀÌÇ༶À¯
    [¿¾ ¿ë¾î] ÀÌÇàºÎ¼¶À¯
  • Gingival fiber
    ÀÕ¸ö¼¶À¯
    [¿¾ ¿ë¾î] Ä¡Àº¼¶À¯
  • Autonomic nerve fiber
    ÀÚÀ²½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ÀÚÀ²½Å°æ¼¶À¯
  • Central fiber
    Á߽ɼ¶À¯
    [¿¾ ¿ë¾î] Á߽ɼ¶À¯
  • Axon [Olfactory nerve fiber]
    Ãà»è [Èİ¢½Å°æ¼¶À¯]
    [¿¾ ¿ë¾î] Ãà»è
  • Interdental fiber
    Ä¡¾Æ»çÀ̼¶À¯
    [¿¾ ¿ë¾î] Ä¡°£¼¶À¯
  • Elastic fiber
    ź·Â¼¶À¯
    [¿¾ ¿ë¾î] ź·Â¼¶À¯
  • Parallel nerve fiber
    ÆòÇ༶À¯
    [¿¾ ¿ë¾î] ÆòÇà½Å°æ¼¶À¯
  • Predentinal fiber
    Dz»ó¾ÆÁú¼¶À¯
    [¿¾ ¿ë¾î] »ó¾ÆÀüÁú¼¶À¯
  • Nuclear bag fiber
    ÇÙÁָӴϱÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ³¶
  • Perivascular nerve fiber
    Ç÷°üÁÖÀ§½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] Ç÷°üÁÖÀ§½Å°æ¼¶À¯
  • Efferent nerve fiber
    ³¯½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¼öÃâ½Å°æ¼¶À¯
  • White muscle fiber
    ¹é»ö±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ¹é¼¶À¯
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • epsilon chain
    ÀԽǷР»ç½½
  • equivalent chain length
    µî(Ôõ)»ç½½ ±æÀÌ
  • food chain
    ¸ÔÀÌ »ç½½
  • gamma chain
    °·¸¶ »ç½½
  • Gaussian chain
    °¡¿ì½º »ç½½
  • H chain
    H »ç½½
  • heavy chain
    Áß(ñì)»ç½½
  • heavy-chain class switching
    Áß(ñì)»ç½½ À¯(×¾) ¹Ù²Ù±â
  • heavy-chain disease
    Áß(ñì)»ç½½ Áúȯ(òðü´)
  • immunoglobulin chain
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° »ç½½
  • J chain
    J »ç½½
  • kappa chain
    Ä«ÆÄ»ç½½
  • lambda chain
    ¶÷´Ù »ç½½
  • L-chain
    L»ç½½
  • light chain
    °æ(Ìî)»ç½½
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FOG fast oxidative glycolytic [fiber]
HCLF high carbohydrate, low fiber [diet]
HFAK hollow-fiber artificial kidney
HFD hemorrhagic fever of deer; high-fiber diet; high forceps delivery; hospital field director; human fa...
LFD lactose-free diet; large for date [fetus]; late fetal death; lateral facial dysplasia; least fatal d...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MVCF Mean velocity of circumferential fiber shortening
mean Vcf Mean velocity of circumferential fiber shortening
MF Mossy Fiber
MFCV Muscle fiber conduction velocity
NFL Nerve fiber layer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • C-fiber nociceptor
    C ¼¶À¯ Ä§ÇØ ¼ö¿ëü, C ¼¶À¯ À¯ÇØ ¼ö¿ë±â
  • calcified collagen fiber
    ¼®È¸È­ ±³¿ø ¼¶À¯
  • cholinergic postganglionic fiber
    Äݸ°¼º ÀýÈÄ ¼¶À¯
  • ciliocapsular fiber
    ¸ð¾çü ¼öÁ¤Ã¼ ³¶ ¼¶À¯
  • cochlear fiber
    ¿Í¿ì ½Å°æ
    ³»ÀÌ ½Å°æ °¡¿îµ¥ û°¢À» ÀüÇÏ´Â Áö°¢ ½Å°æ ¼¶À¯ÀÇ ´Ù¹ßÀ» ¿Í¿ì½Å°æ ¶Ç´Â û½Å°æÀ̶ó ÇÑ´Ù. ÃøµÎ°ñ¿¡ ±â¿ï¾îÁ®ÀÖ´Â ¿Í¿ìÀÇ °ñÃà¼Ó¿¡¼­ ³ª¼± ½Å°æÀýÀ» ¸¸µé¾î ¿Í¿ìÀÇ ³ª¼±±â¿¡ ºÐÆ÷Çϰí û°¢À» °üÀåÇÑ´Ù.
  • collagen fiber
    ±³¿ø ¼¶À¯
  • collagen fiber web
    ±³¿ø ¼¶À¯ ±×¹°
  • connective tissue fiber
    °áÇÕ Á¶Á÷ ¼¶À¯
  • elastic fiber
    ź·Â ¼¶À¯
    ¿¤¶ó½ºÆ¾À̶ó´Â ´Ü¹éÁú·Î µÇ¾î Àִµ¥, ¿¤¶ó½ºÆ¾Àº ¼¶À¯ ¸ð¾çÀ̳ª ÃþÆÇ ¸ð¾çÀ¸·Î Á¸ÀçÇÏ¸ç µ¿¸Æ º®, ź·Â Àδë, ¼¼±â°üÁö, ÇǺÎ, ź·Â ¿¬°ñ µîÀÇ ÁÖµÈ ±¸¼º ¿ä¼Ò°¡ µÈ´Ù.
  • fast fiber
    ¼Ó¼¶À¯
  • fast-twitch fiber muscle
    ½Å¼Ó ¿¬Ãà±Ù ¼¶À¯
  • FGP : functionally generated pathÀÇ ¾àÀÚ.

    fiber

    ¼¶À¯
    ±æ°í ½Ç°°Àº ±¸Á¶³ª À§ Àå°ü È¿¼Ò¿¡ ÀÇÇØ ¼ÒÈ­µÇÁö ¾ÊÀº À½½Ä¹°ÀÇ ±¸¼º ¼ººÐ.
  • fiber distributed data interface
    ±¤ ³×Æ®¿öÅ©
  • fiber optic
    ±¤¼¶À¯
    ÀÚ½ÅÀÇ ±æÀÌ ¹æÇâÀ¸·Î ºûÀ̳ª ¹æ»ç ¿¡³ÊÁöÀÇ Àü´ÞÀÌ °¡´ÉÇÑ Åõ¸íÇÑ ¼¶À¯°¡´Ú ȤÀº ´Ù¹ß
  • fiber optic delivery system
    ±¤ ¼¶À¯ Àü´Þ°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
closed chain compound Any compound in which the constituent atoms, or any part of them, form a ring. Used mainly in organic chemistry where: 1) numerous compound's contain rings of carbon atoms (carbocyclic compound's) or carbon atoms plus one or more atoms of other types (heterocyclic compound's), usually nitrogen, oxygen, or sulfur; 2) where the atoms in the ring are all of the same element (homocyclic or isocyclic compound); 3) where the ring is saturated or contains nonconjugated double bonds (alicyclic compound), the compound is similar in properties to the corresponding acyclic compound (e.g., cyclohexane resembles hexane); 4) where the ring contains conjugated double bonds in a closed loop in which there are 4n + 2 (where n is an integer) delocalised π electrons (Huckel's rule) (aromatic compound; e.g., benzene, pyridine), it is more stable than the corresponding saturated ring and exhibits unusual chemical properties characteristic of itself and not of other types of rings or of acyclic compound's. These aromatic compounds have the ability to sustain an induced ring current.
Synonym: closed chain compound, ring compound.
(05 Mar 2000)
cold chain A system of protection against high environmental temperatures for heat-labile vaccines, sera and other biological preparations.
(05 Mar 2000)
P light chain <protein> Myosin light chain that can be phosphorylated by myosin light chain kinase, as a result of phosphorylation, the myosin is activated.
(18 Nov 1997)
corticosteroid side-chain-isomerase <enzyme> Converts 11-deoxycorticosterone to 20-hydroxy-3-oxypregn-4-en-21-al; also acts as an epimerase at c-20
Registry number: EC 5.3.1.21
Synonym: corticosteroid side chain isomerase, ccsci
(26 Jun 1999)
polymerase chain reaction <molecular biology, technique> The first practical system for in vitro amplification of DNA and as such one of the most important recent developments in molecular biology.
Two synthetic oligonucleotide primers, which are complementary to two regions of the target DNA (one for each strand) to be amplified, are added to the target DNA (that need not be pure), in the presence of excess deoxynucleotides and Taq polymerase, a heat stable DNA polymerase. In a series (typically 30) of temperature cycles, the target DNA is repeatedly denatured (around 90_C), annealed to the primers (typically at 50-60_C) and a daughter strand extended from the primers (72_C). As the daughter strands themselves act as templates for subsequent cycles, DNA fragments matching both primers are amplified exponentially, rather than linearly.
The original DNA need thus be neither pure nor abundant and the polymerase chain reaction has accordingly become widely used not only in research, but in clinical diagnostics and forensic science.
Acronym: PCR
(14 Oct 1997)
MyoD heavy chain kinase <enzyme> Required for actin activation of the magnesium atpase activity of dictyostelium myosin id (myod); specific for myod
Registry number: EC 2.7.1.-
Synonym: 110-kD protein kinase, dictyostelium, dictyostelium 110-kD protein
(26 Jun 1999)
myosin heavy chain <protein> See myosin: do not confuse with heavy meromyosin which is a subfragment of the heavy chain of myosin II.
(18 Nov 1997)
myosin light chain <protein> The light chains of the muscle protein myosin. Each molecule of myosin is composed of two heavy chains and two pairs of light chains. The light chains have a molecular weight of about 20 kD and there is one dissimilar pair of light chains associated with each heavy chain.
The proteins all have sequence homology to calmodulin, but not all with calcium binding activity.
Several types are known: regulatory light chains (LC 2, DNTB light chains) probably regulate the ATPase activity of the heavy chain directly (through the binding of calcium) or indirectly (activating when they themselves are phosphorylated by myosin light chain kinase) and essential light chains (LC 1, LC 3, alkali light chains), which have a more subtle and apparently nonessential role.
In molluscan muscle the EDTA light chains (similar to LC 2 from vertebrate muscle) confer calcium sensitivity on the myosin itself.
The light chains are "calmodulin-like" proteins that bind calcium. Two of them can be removed easily, and two with difficulty. The light chains bind the heavy chains in the vicinity of the head groups of the myosin.
(12 Dec 1998)
myosin light chain kinase <enzyme> An enzyme that phosphorylates myosin light chains in the presence of ATP to yield myosin-light chain phosphate and ADP, and requires calcium and calmodulin.
The 20-kD light chain is phosphorylated more rapidly than any other acceptor, but light chains from other myosins and myosin itself can act as acceptors. The enzyme plays a central role in the regulation of smooth muscle contraction.
Chemical name: ATP:myosin-light-chain O-phosphotransferase
Registry number: EC 2.7.1.117
(12 Dec 1998)
haemolytic chain The haemolysis that occurs when complement is activated by the previously formed union of erythrocytes and specific antibody.
(05 Mar 2000)
H chain <protein> Heavy chain of immunoglobulin, see IgG, IgM, etc.
(18 Nov 1997)
heavy chain <protein> In general, the larger polypeptide in a multimeric protein. Thus the immunoglobulin heavy chain is of 50 kD, the light chain of 22 kD, whereas in myosin the heavy chain is very much larger (220 kD) than the light chains (~20 kD).
(18 Nov 1997)
heavy chain disease A disorder of immunoglobulin synthesis in which large quantities of abnormal heavy chains are excreted in the urine. The amino acid sequences of the n- (amino-) terminal regions of these chains are normal, but they have a deletion extending from part of the variable domain through the first domain of the constant region, so that they cannot form cross-links to the light chains. The defect arises through faulty coupling of the variable (v) and constant (c) region genes.
(12 Dec 1998)
xenobiotic medium chain fatty acid - coenzyme A ligase <enzyme> Partial amino acid sequence of enzyme from bovine liver mitochondria given I first source; has high sequence homology to human and rat sa protein
Registry number: EC 6.2.1.-
Synonym: xl-i ligase, xl-i carboxylic acid - CoA ligase
(26 Jun 1999)
short chain In bacteriology, a string of two to eight cells.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chain pump
    »ç½½ ÆßÇÁ(»ç½½¿¡ ¹öŶÀ» ´Þ¾Æ ÆÛ¿ï¸®´Â ÀåÄ¡)
  • chain reaction
    ¿¬¼â ¹ÝÀÀ;(»ç°Ç µîÀÇ)¿¬¼â ¹ÝÀÀ
  • chain reactor
    ¿¬¼â ¹ÝÀÀ ÀåÄ¡;¿øÀÚ·Î
  • chain rule
    ¿¬¼â ¹ýÄ¢
  • chain saw
    ÈÞ´ë¿ë µ¿·Â »ç½½Åé;üÀμÒ
  • chain shot
    »ç½½Åº(ÇØÀü¿¡¼­ µÀ´ë µîÀ» ÆÄ±«Çϱâ À§ÇØ ¾´ ¼è»ç½½·Î ÀÌÀº µÎ°³ÀÇ ´ëÆ÷¾Ë)
  • chain smoker
    ÁÙ´ã¹è ÇÇ¿ì´Â »ç¶÷
  • chain stitch
    (...À») »ç½½ ¸ð¾çÀ¸·Î ¶ß´Ù
  • chain store
    üÀνºÅä¾î;¿¬¼âÁ¡
  • chain-react
    ¿¬¼â ¹ÝÀÀÀ» ÀÏÀ¸Å°´Ù
  • chain-reacting pile
    ¿¬¼â¹ÝÀÀ·Î;¿øÀÚ·Î
  • chain-smoke
    ÁÙ´ã¹è¸¦ ÇÇ¿ì´Ù;(´ã¹è¸¦) ÀÕ´Þ¾Æ ÇÇ¿ì´Ù
  • chain-wheel
    (ÀÚÀü°Å µîÀÇ) »ç½½ Åé´Ï¹ÙÄû
  • chain-work
    »ç½½ ¼¼°ø;»ç½½ ¹«´Ì
  • closed chain
    Æó¼â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á